Feline Leukemia Virus: Treatment Advances and Welfare
New treatment approaches for FeLV-positive cats are improving welfare outcomes, challenging older assumptions that infection means certain rapid death.
Key Facts
- FeLV is a retrovirus that suppresses the immune system and causes tumors in infected cats
- Approximately 2-3% of UK cats are FeLV-positive; higher in stray and multi-cat households
- Regressive infection (controlled by immune system) is more common than previously thought
- Antiviral therapies including feline interferon-omega may improve quality of life
- FeLV-positive cats can live for years with good quality of life with appropriate management
Welfare Considerations
Welfare for FeLV-positive cats has historically been framed around euthanasia decisions, but evolving understanding of infection outcomes and new treatment options offer more nuanced welfare pathways. Cats with regressive infection maintain immune control and may live normal lifespans with careful monitoring. Those with progressive infection develop immune suppression and are at risk of lymphoma and secondary infections, but quality of life can be maintained for meaningful periods with antiviral therapy, disease monitoring, and prompt treatment of secondary conditions. The welfare decision framework for FeLV-positive cats requires individualized assessment of infection stage, quality of life, and treatment response rather than automatic euthanasia at diagnosis.
What You Can Do
- Request FeLV staging including viral load testing to understand your cats infection status
- Discuss antiviral therapy options including feline interferon-omega with a feline medicine specialist
- Maintain FeLV-positive cats as indoor-only to prevent spread and reduce secondary infection risk
- Monitor monthly for signs of secondary infections and lymphoma through regular veterinary checks
- Contact FeLV-specialist organizations for support and current treatment guidelines